DK0858330T3 - Præparater indeholdende derivater af hydroperoxyeicosatetraensyre og fremgangsmåder til anvendelse ved behandling af sygdom - Google Patents
Præparater indeholdende derivater af hydroperoxyeicosatetraensyre og fremgangsmåder til anvendelse ved behandling af sygdomInfo
- Publication number
- DK0858330T3 DK0858330T3 DK96928944T DK96928944T DK0858330T3 DK 0858330 T3 DK0858330 T3 DK 0858330T3 DK 96928944 T DK96928944 T DK 96928944T DK 96928944 T DK96928944 T DK 96928944T DK 0858330 T3 DK0858330 T3 DK 0858330T3
- Authority
- DK
- Denmark
- Prior art keywords
- methods
- compositions containing
- disease
- treatment
- containing derivatives
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/04—Artificial tears; Irrigation solutions
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Ophthalmology & Optometry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/551,021 US5696166A (en) | 1995-10-31 | 1995-10-31 | Compositions containing hydroxyeicosatetraenoic acid derivatives and methods of use in treating dry eye disorders |
PCT/US1996/013441 WO1997016179A1 (en) | 1995-10-31 | 1996-08-19 | Compositions containing hydroperoxyeicosatetraenoic acid derivatives and methods of use in treating dry eye disorders |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0858330T3 true DK0858330T3 (da) | 2001-01-02 |
Family
ID=24199512
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK96928944T DK0858330T3 (da) | 1995-10-31 | 1996-08-19 | Præparater indeholdende derivater af hydroperoxyeicosatetraensyre og fremgangsmåder til anvendelse ved behandling af sygdom |
Country Status (13)
Country | Link |
---|---|
US (1) | US5696166A (da) |
EP (1) | EP0858330B1 (da) |
JP (1) | JPH11515024A (da) |
AT (1) | ATE198044T1 (da) |
AU (1) | AU706373B2 (da) |
CA (1) | CA2234367C (da) |
DE (1) | DE69611251T2 (da) |
DK (1) | DK0858330T3 (da) |
ES (1) | ES2152556T3 (da) |
GR (1) | GR3035438T3 (da) |
HK (1) | HK1013194A1 (da) |
PT (1) | PT858330E (da) |
WO (1) | WO1997016179A1 (da) |
Families Citing this family (60)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20010073153A (ko) * | 1998-09-18 | 2001-07-31 | 제임스 에이. 아노 | 녹내장 치료용의 세로토닌성 5ht2 작용제 |
US6462080B1 (en) | 1998-12-24 | 2002-10-08 | Alcon Manufacturing, Ltd. | Prostaglandin E receptor agonists for treatment of dry eye |
AU2183900A (en) | 1998-12-24 | 2000-07-31 | Alcon Laboratories, Inc. | Ep4 receptor agonists for treatment of dry eye |
TWI225398B (en) * | 1999-07-14 | 2004-12-21 | R Tech Ueno Ltd | Composition for treatment of external secretion disorders |
US6320062B1 (en) | 1999-11-09 | 2001-11-20 | Alcon Universal Ltd. | 15-hydroxyeicosatetraenoic acid analogs with enhanced metabolic stability and methods of their use in treating dry eye disorders |
US6353032B1 (en) | 1999-11-09 | 2002-03-05 | Alcon Universal Ltd. | Phospholipids of hydroxyeicosatetraenoic acid-like derivatives and methods of use |
AU1101301A (en) * | 1999-11-09 | 2001-06-06 | Alcon Universal Limited | 2,2-difluoro 15-hydroxyeicosatetraenoic acid analogs and methods of use |
DE60019322T2 (de) | 1999-11-09 | 2005-09-08 | Alcon Inc. | Heteroatomunterbrochene analoge von15-hydroxyeicosatetraensäure und verfahren zu deren verwendung |
US6342525B1 (en) | 1999-11-09 | 2002-01-29 | Alcon Universal Ltd. | Benzenoid derivatives of 15-hydroxyeicosatetraenoic acid and methods of their use in treating dry eye disorders |
BR0015404A (pt) | 1999-11-09 | 2002-06-25 | Alcon Inc | Compostos relacionados com ácido 15-hidroxieicosatetraenóico e métodos de uso |
AU776146B2 (en) * | 1999-11-09 | 2004-08-26 | Alcon Inc. | 3-heteroatom substituted and two carbon homologs of 15-HETE and methods of use |
ES2220559T3 (es) * | 1999-11-09 | 2004-12-16 | Alcon Inc. | Analogos del acido hidroxieicosatetraenoico y metodos de uso en el tratamiento de transtornos de ojo seco. |
CA2386878A1 (en) * | 1999-11-09 | 2001-05-17 | Peter G. Klimko | Lipoxin a4 and its analogs for the treatment of dry eye |
US6803385B2 (en) | 1999-11-09 | 2004-10-12 | Alcon, Inc. | Hydroxyeicosatetraenoic acid analogs and methods of their use in treating dry eye disorders |
DK1228031T3 (da) * | 1999-11-09 | 2004-04-13 | Alcon Inc | Omegakædemodificerede 15-hydroxyeicosatetraensyrederivater, der er egnede til behandling af øjentørhed |
US6458854B2 (en) | 1999-11-09 | 2002-10-01 | Alcon Universal Ltd. | Phospholipids of hydroxyeicosatetraenoic acid-like derivatives and methods of use |
ES2242643T3 (es) * | 1999-11-09 | 2005-11-16 | Alcon Inc. | Sales de hidroxieicosatetraenoato, composiciones y metodos de uso en el tratamiento de trastornos del ojo seco. |
US6552084B2 (en) | 1999-11-09 | 2003-04-22 | Alcon Universal Ltd. | Hydroxyeicosatetraenoic acid analogs and methods of their use in treating dry eye disorders |
CA2386619A1 (en) * | 1999-11-09 | 2001-05-17 | Alcon, Inc. | Compositions containing hydroxyeicosatetraenoic acid derivatives and methods of use in treating dry eye disorders |
EP1418167B1 (en) * | 1999-11-09 | 2005-01-26 | Alcon Inc. | Hydroxyeicosatetraenoic acid analogs and methods of their use in treating dry eye disorders |
US6576663B2 (en) | 1999-12-22 | 2003-06-10 | Alcon, Inc. | 6-Keto prostaglandin F1α and analogs for treating dry eye |
US6277855B1 (en) * | 2000-04-21 | 2001-08-21 | Inspire Pharmaceuticals, Inc. | Method of treating dry eye disease with nicotinic acetylcholine receptor agonists |
WO2002034258A1 (en) * | 2000-10-23 | 2002-05-02 | Alcon, Inc. | Use of hydroxyeicosatetraenoic acid derivatives in intraocular surgery |
US20020077358A1 (en) * | 2000-10-23 | 2002-06-20 | Alcon Universal Ltd. | Use of hydroperoxyeicosatetraenoic acid derivatives following refractive surgery |
US8168616B1 (en) | 2000-11-17 | 2012-05-01 | Novartis Ag | Combination comprising a renin inhibitor and an angiotensin receptor inhibitor for hypertension |
US20030008853A1 (en) * | 2001-05-21 | 2003-01-09 | Alcon, Inc. | Method for treating dry eye disorders |
AU2002308760B2 (en) | 2001-05-21 | 2006-05-11 | Alcon, Inc. | Use of proteasome inhibitors to treat dry eye disorders |
US7112588B2 (en) * | 2001-05-21 | 2006-09-26 | Alcon, Inc. | Use of proteasome inhibitors to treat dry eye disorders |
US6872382B1 (en) | 2001-05-21 | 2005-03-29 | Alcon, Inc. | Use of selective PDE IV inhibitors to treat dry eye disorders |
DE60213230T2 (de) | 2001-05-21 | 2006-11-23 | Alcon Inc. | Verwendung von NF-Kappa.B Inhibitoren zur Behandlung von Augentrockenheit |
US6645994B1 (en) | 2001-06-01 | 2003-11-11 | Alcon, Inc. | Method of treating dry eye disorders |
US6750250B1 (en) | 2001-07-12 | 2004-06-15 | Alcon, Inc. | 11,12-oxidoarachidonic acid derivatives and methods of their use in treating dry eye disorders |
EP1438037A1 (en) * | 2001-10-11 | 2004-07-21 | Alcon, Inc. | Methods for treating dry eye by a combination of an antiinflammatory steroid and a muc-1 secretagogue |
US20030109508A1 (en) * | 2001-10-11 | 2003-06-12 | Alcon, Inc. | Methods for treating dry eye |
WO2003030892A1 (en) * | 2001-10-11 | 2003-04-17 | Alcon, Inc. | Methods for treating dry eye |
AU2003221707A1 (en) * | 2002-06-14 | 2003-12-31 | Alcon, Inc. | Topical use of hydroxyeicosatetraenoic acid compounds to treat psoriasis |
EP1583527A1 (en) * | 2002-06-14 | 2005-10-12 | Alcon, Inc. | Use of hydroxyeicosatetraenoic acid compounds to treat ophthalmic inflammatory disorders |
FR2843026B1 (fr) * | 2002-08-02 | 2006-01-06 | Goemar Lab Sa | Nouveau medicament |
PL374700A1 (en) * | 2002-09-20 | 2005-10-31 | Alcon, Inc. | Use of cytokine synthesis inhibitors for the treatment of dry eye disorders |
US20060217325A1 (en) * | 2002-12-20 | 2006-09-28 | Alcon, Inc. | Treatment of dry eye restoring 15-lipoxygenase activity to ocular surface cells |
WO2004093878A1 (en) | 2003-04-16 | 2004-11-04 | Alcon, Inc. | Use of fused pyridazine derivatives for treating dry eye disorders |
US8455016B2 (en) | 2004-03-12 | 2013-06-04 | Melbj Holdings, Llc | Treatment for meibomian gland dysfunction or obstruction |
US20050202097A1 (en) * | 2004-03-12 | 2005-09-15 | Melbj Holdings, Llc, Florida | Lubricant for the ocular surface |
US7923471B2 (en) * | 2004-05-14 | 2011-04-12 | Alcon, Inc. | Method of treating dry eye disorders and uveitis |
US20050256189A1 (en) * | 2004-05-14 | 2005-11-17 | Alcon, Inc. | Method of treating dry eye disorders and uveitis |
US7223737B1 (en) | 2004-08-13 | 2007-05-29 | Alcon, Inc. | Method of treating dry eye disorders using glycosides |
JPWO2006022291A1 (ja) * | 2004-08-27 | 2008-05-08 | 千寿製薬株式会社 | ドライアイ治療用点眼液 |
WO2006065916A1 (en) * | 2004-12-14 | 2006-06-22 | Alcon, Inc. | Method of treating dry eye disorders using 13(s)-hode and its analogs |
US7745461B1 (en) | 2006-02-27 | 2010-06-29 | Alcon Research, Ltd. | Method of treating dry eye disorders |
CN101743009A (zh) * | 2007-07-11 | 2010-06-16 | 辉瑞大药厂 | 治疗干眼病的药物组合物和方法 |
US20090048368A1 (en) * | 2007-08-13 | 2009-02-19 | Bash Thomas F | Polyolefin compositions comprising bio-based starch materials |
JP5421272B2 (ja) * | 2007-10-12 | 2014-02-19 | リゾルヴィクス・ファーマシューティカルズ・インコーポレイテッド | 眼病治療のための組成物及び方法 |
AU2014201375B2 (en) * | 2007-10-12 | 2015-11-05 | Resolvyx Pharmaceuticals, Inc. | Omega-3 fatty acids, hydroxy polyunsaturated fatty acids, lipoxin compounds, or oxylipin compounds for the treatment of ophthalmic conditions |
WO2009052140A1 (en) * | 2007-10-15 | 2009-04-23 | Alcon Research, Ltd. | Use of tnf receptor antagonists for treating dry eye |
TW200927192A (en) * | 2007-11-19 | 2009-07-01 | Alcon Res Ltd | Use of TRPV1 receptor antagonists for treating dry eye and ocular pain |
US8207226B1 (en) | 2008-06-03 | 2012-06-26 | Alcon Research, Ltd. | Use of FAAH antagonists for treating dry eye and ocular pain |
GB0907413D0 (en) | 2009-04-29 | 2009-06-10 | Equateq Ltd | Novel methods |
BR112012010586A2 (pt) * | 2009-11-06 | 2016-03-22 | Alcon Res Ltd | suplementos nutricionais para alívio de segura no olho. |
CN105899485B (zh) * | 2013-11-15 | 2018-10-19 | 尊严科学有限公司 | 多不饱和羟基脂肪酸的药学上可接受的盐 |
US20190177407A1 (en) | 2016-06-20 | 2019-06-13 | Novartis Ag | Methods of treating dry eye disease using tnf alpha antagonists |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3991759A (en) * | 1975-10-28 | 1976-11-16 | Alza Corporation | Method and therapeutic system for treating aqueous deficient dry eye |
US4131651A (en) * | 1977-10-25 | 1978-12-26 | Barnes-Hind Pharmaceuticals, Inc. | Treatment of dry eye |
US4409205A (en) * | 1979-03-05 | 1983-10-11 | Cooper Laboratories, Inc. | Ophthalmic solution |
US4370325A (en) * | 1979-03-30 | 1983-01-25 | Dermik Laboratories | Pharmaceutical compositions and method of treatment |
AU546872B2 (en) * | 1982-06-16 | 1985-09-26 | Unilever Plc | Skin treatment compositions containing a fatty acid or ester |
GB8319073D0 (en) * | 1983-07-14 | 1983-08-17 | Efamol Ltd | Fatty acid compositions |
US4883658A (en) * | 1986-04-28 | 1989-11-28 | Holly Frank J | Ophthalmic solution for treatment of dry-eye syndrome |
US4744980A (en) * | 1986-04-28 | 1988-05-17 | Holly Frank J | Ophthalmic solution for treatment of dry eye syndrome |
US4818537A (en) * | 1986-10-21 | 1989-04-04 | Liposome Technology, Inc. | Liposome composition for treating dry eye |
US4966773A (en) * | 1986-11-25 | 1990-10-30 | Alcon Laboratories, Inc. | Topical ophthalmic compositions containing microfine retinoid particles |
US4914088A (en) * | 1987-04-02 | 1990-04-03 | Thomas Glonek | Dry eye treatment solution and method |
US4906467A (en) * | 1988-03-24 | 1990-03-06 | New York Medical College | Novel, long-duration treatment for glaucoma |
US5075104A (en) * | 1989-03-31 | 1991-12-24 | Alcon Laboratories, Inc. | Ophthalmic carboxy vinyl polymer gel for dry eye syndrome |
US5041434A (en) * | 1991-08-17 | 1991-08-20 | Virginia Lubkin | Drugs for topical application of sex steroids in the treatment of dry eye syndrome, and methods of preparation and application |
ATE132366T1 (de) * | 1990-05-29 | 1996-01-15 | Boston Ocular Res | Zusammensetzung zur behandlung von dry eye erkrankungen |
US5102670A (en) * | 1990-09-14 | 1992-04-07 | Abraham Nader G | Method for treating eye disorders by reducing 12(r)-hydroxyeicosatetraenoic acid and 12(r)-dihydroxyeicosatrienoic acid levels |
JP2594486B2 (ja) * | 1991-01-15 | 1997-03-26 | アルコン ラボラトリーズ インコーポレイテッド | 局所的眼薬組成物 |
EP0546728A3 (en) * | 1991-12-13 | 1993-09-08 | Alcon Laboratories Inc | Physiological tear compositions and methods for their preparation |
US5290572A (en) * | 1992-08-06 | 1994-03-01 | Deo Corporation | Opthalmic composition for treating dry eye |
US5358706A (en) * | 1992-09-30 | 1994-10-25 | Union Carbide Chemicals & Plastics Technology Corporation | Muco-adhesive polymers |
US5389383A (en) * | 1993-06-18 | 1995-02-14 | Allergan, Inc. | Method for treating hypoxia-associated ocular complications |
-
1995
- 1995-10-31 US US08/551,021 patent/US5696166A/en not_active Expired - Lifetime
-
1996
- 1996-08-19 AU AU68516/96A patent/AU706373B2/en not_active Ceased
- 1996-08-19 WO PCT/US1996/013441 patent/WO1997016179A1/en active IP Right Grant
- 1996-08-19 DK DK96928944T patent/DK0858330T3/da active
- 1996-08-19 CA CA002234367A patent/CA2234367C/en not_active Expired - Fee Related
- 1996-08-19 ES ES96928944T patent/ES2152556T3/es not_active Expired - Lifetime
- 1996-08-19 DE DE69611251T patent/DE69611251T2/de not_active Expired - Fee Related
- 1996-08-19 JP JP9517306A patent/JPH11515024A/ja not_active Abandoned
- 1996-08-19 AT AT96928944T patent/ATE198044T1/de not_active IP Right Cessation
- 1996-08-19 EP EP96928944A patent/EP0858330B1/en not_active Expired - Lifetime
- 1996-08-19 PT PT96928944T patent/PT858330E/pt unknown
-
1998
- 1998-12-22 HK HK98114675A patent/HK1013194A1/xx not_active IP Right Cessation
-
2001
- 2001-02-20 GR GR20010400269T patent/GR3035438T3/el not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
WO1997016179A1 (en) | 1997-05-09 |
US5696166A (en) | 1997-12-09 |
CA2234367A1 (en) | 1997-05-09 |
CA2234367C (en) | 2002-06-04 |
DE69611251D1 (de) | 2001-01-18 |
PT858330E (pt) | 2001-03-30 |
AU706373B2 (en) | 1999-06-17 |
ES2152556T3 (es) | 2001-02-01 |
DE69611251T2 (de) | 2001-04-05 |
AU6851696A (en) | 1997-05-22 |
EP0858330A1 (en) | 1998-08-19 |
EP0858330B1 (en) | 2000-12-13 |
GR3035438T3 (en) | 2001-05-31 |
ATE198044T1 (de) | 2000-12-15 |
JPH11515024A (ja) | 1999-12-21 |
HK1013194A1 (en) | 1999-08-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0858330T3 (da) | Præparater indeholdende derivater af hydroperoxyeicosatetraensyre og fremgangsmåder til anvendelse ved behandling af sygdom | |
DK1039912T3 (da) | Angiostatiske midler og præparater til behandling af GLC1A-glaukom | |
NO972972D0 (no) | Sammensetninger for behandling av dermatologiske forstyrrelser og metoder for deres anvendelse | |
BR9811099A (pt) | Inibidores de urocinase | |
MXPA02004703A (es) | Composiciones que contienen derivados de acido hidroxieicostetraenoico y metodos de uso para tratar trastornos de resequedad en los ojos. | |
NO981810D0 (no) | Sammensetninger og fremgangsmÕter for behandling av tilstander ved bensvikt | |
ATE233738T1 (de) | Kleine moleküle anwendbar in der behandlung von entzündgskrankheiten | |
NO20013155L (no) | Fremgangsmate ved anvendelse av cyklooksygenase-2-inhibitor og ett eller flere antineoplastiske midler som enkombinasjonsterapi i behandlingen av neoplasi | |
NO972451L (no) | Heterosyklyloksy- og tiometyl-1,2,5-tiadiazolidin-3-on 1,1-dioksyder og preparater og fremgangsmåte for anvendelse derav | |
DK0804437T3 (da) | [a]-Annelerede pyrrolderivater og deres anvendelse i farmacien | |
PL329940A1 (en) | Compositions for once-a-day administration for use in treating diseases involving mediator effect of cyclooxygenase-2 | |
NO972391D0 (no) | 2-substituerte 1,2,5-tiadiazolidin-3-on 1,1-dioksider og preparater og metoder for anvendelse derav | |
DE69613693D1 (de) | 2-heteroarylalkenylderivate der cyclopentano-heptan(heptaen)säure als therapeutisches mittel zur behandlung des erhöhten augeninnendruckes | |
DE69613386D1 (de) | Carbostyrilderivat zur behandlung von ophthalmologischen erkrankungen | |
DK0837935T3 (da) | Den 3'-ikke-translaterede region af det humane prohibitin-gen | |
DK0986393T3 (da) | Anvendelse af et nitroxid eller et prodrug heraf ved profylaktisk og terapeutisk behandling af cancer | |
MXPA02004702A (es) | Analogos interrumpidos por heteroatomos de acido 15-hidroxieicosatetraenoico y metodos de uso. | |
DK1237562T3 (da) | Fremgangsmåde til fremstilling af mikania-ekstrakter, som indeholder mikanolid og dihydromikanolid, og anvendelse i behandlingen af prolifererende sygdomme | |
NO970573L (no) | Ylidenforbindelser og deres fremstilling | |
MXPA02004699A (es) | Derivados de acidos hidroxieicosatetraenoico modificados con cadena omega y metodos de su uso para el tratameinto del ojo reseco. | |
MXPA02004700A (es) | Compuestos relacionados con acido 15-hidroxieicosatetraenoico y metodos de uso. | |
NO985974D0 (no) | Piperidineddiksyrederivater og deres anvendelse ved behandling av trombose-sykdommer | |
WO2001034553A3 (en) | 2,2-difluoro 15-hydroxyeicosatetraenoic acid analogs and methods of use | |
LV11593A (lv) | Dimetikona pielietojums aizcietejumu arstesana | |
ES2190581T3 (es) | 2-aminotetralina opticamente activa, procedimiento para su preparacion y composiciones farmaceuticas que la contienen, activa en la prevencion y tratamiento de shock septico. |